B-Cell Depletion Therapy: The Primary Biological Segment in the IgG4-Related Disease Market
The discovery that B-cells play a central role in the pathogenesis of fibro-inflammatory diseases has opened new therapeutic doors. Targeted product types designed to deplete specific B-cell populations have shown remarkable efficacy in clinical trials. By removing the cells responsible for driving the inflammatory cascade, these therapies can achieve deep and lasting remission. This...
0 التعليقات 0 المشاركات 53 مشاهدة 0 معاينة